hackint0sh/New-Dataset huggingface dataset:
2. Length of Hospitalization conditions: Acute Bronchiolitis Due to Respiratory Syncytial Virus studyType: INTERVENTIONAL phases: PHASE3 allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Patients with acute bronchiolitis after informed written consent will be divided into two groups randomly. Group I will be nebulized with adrenaline every 6 hours and group II will nebulized with hypertonic saline every 6 hours. After 24 hours and 48 hours of nebulization, WDF score will be recorded by measuring respiratory rate, heart rate, chest retractions, chest auscultation findings and SPO₂ levels. Researcher will record all data on a specified Performa. primaryPurpose: TREATMENT masking: DOUBLE maskingDescription: Investigator will make all the protocol and research Performa. Drugs will already be prepared for nebulization and labelled by investigator. Researcher /care provider will nebulize the patients of both groups randomly and record the results accordingly. whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER count: 60 type: ESTIMATED name: Hypertonic Saline Solution, 1 Ml name: Adrenaline measure: Wood-Downes-Ferres clinical score calculation measure: total length of hospitalization sex: ALL minimumAge: 1 Month maximumAge: 2 Years stdAges: CHILD facility: Combined Military Hospital status: RECRUITING city: Nowshera state: KPK zip: 24110 country: Pakistan name: Syed Qamar Zaman role: CONTACT phone: 00923365307823 email: dr.qamarzaman@hotmail.com name: Shahid Mahmud role: CONTACT phone: 00923315301289 email: childspec@hotmail.com name: Syed Qamar Zaman role: PRINCIPAL_INVESTIGATOR hasResults: False
nctId: NCT06267105 id: A1-LORT briefTitle: A Clinical Study to Compare Functional Outcomes After Surgery Using a Transverse or Longitudinal Surgical Incision in the Skin. overallStatus: NOT_YET_RECRUITING date: 2024-02 date: 2025-02 date: 2025-03 date: 2024-02-20 date: 2024-02-20 name: Corporacion Parc Tauli class: OTHER briefSummary: Trigger finger is a common pathology in the hand. Patients suffer from pain and depending on which tasks, patients have difficulty to perform them. Its treatment in initial and less serious phases includes conservative measures, but failure of these may require releasing the trigger finger with surgery. The surgical technique performed for trigger finger is the opening of the A1 pulley, the skin incisions used for this surgery are various (transverse, longitudinal, oblique). Trigger finger surgery presents good results in terms of resolution, but complications may also occur. The reason for this study is to assess whether there are functional differences using the Dash scale when we perform a transverse or longitudinal incision in trigger finger surgery. conditions: Functional Disturbance as Result studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: SINGLE whoMasked: OUTCOMES_ASSESSOR count: 36 type: ESTIMATED name: Longitudinal incision name: Transverse incision measure: Functional improvement of the patient after surgery measure: Surgeon comfort measure: Resolution measure: Flushed measure: Pain feeling measure: Contracture measure: Infection measure: Nerve injury measure: Return to work measure: Reincorporation to activities measure: Sensitivity Test sex: ALL minimumAge: 18 Years maximumAge: 100 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06267092 id: NN9838-4944 briefTitle: A Study of How CagriSema Works on Appetite in People With Excess Body Weight overallStatus: RECRUITING date: 2024-02-15 date: 2026-01-19 date: 2026-01-19 date: 2024-02-20 date: 2024-02-28 name: Novo Nordisk A/S class: INDUSTRY briefSummary: Part A: The study will look at participants appetite and energy intake and also look at the mechanisms of brain associated with appetite and food intake. Participants will not get any medicine and will be in a group that will be compared to another group receiving a weight-loss medicine. The study will last for about 6 months.
Part B: The study will look at how CagriSema works on participants appetite and energy intake and will be compared with a ''dummy'' medicine. The study will also look at how participants brain works when participants take the medicine. Participants will either get CagriSema or ''dummy'' medicine. conditions: Overweight conditions: Obesity studyType: INTERVENTIONAL phases: PHASE1 allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: QUADRUPLE maskingDescription: Sponsor staff involved in the clinical trial is masked according to company standard procedures. whoMasked: PARTICIPANT whoMasked: CARE_PROVIDER whoMasked: INVESTIGATOR whoMasked: OUTCOMES_ASSESSOR count: 150 type: ESTIMATED name: No treatment given name: Cagrilintide and Semaglutide name: Placebo measure: Change in mean postprandial appetite score based on visual analogue scale (VAS) measure: Change in mean postprandial VAS ratings of: hunger, fullness, satiety and prospective food consumption measure: Change in average DAILY EATS questionnaire scores over one week for: average hunger, worst hunger, appetite, cravings, satiety and eating drivers index composite score measure: Change in control of eating questionnaire (COEQ), 4 domains: craving control score, positive mood score, craving for sweets score and craving for savoury food score measure: Change in power of food questionnaire for: food available score, food present score, food tasted score and composite score measure: Change in blood oxygen level dependant (BOLD) response to food cues in the brain reward areas measure: Relative change in total energy intake during ad libitum lunch, evening meal and snackbox measure: Change in percent energy intake of high fat, sweet food in total ad libitum energy intake in the evening snack box measure: Change in total energy intake during ad libitum lunch, evening meal and snackbox measure: Change in total amount of food consumed during ad libitum lunch, evening meal and snackbox measure: Change in body weight sex: ALL minimumAge: 18 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Charité Research Organisation GmbH status: RECRUITING city: Berlin zip: 10117 country: Germany lat: 52.52437 lon: 13.41053 hasResults: False
nctId: NCT06267079 id: core stability briefTitle: Core Stability, Symmetrical Weight-bearing Stroke overallStatus: COMPLETED date: 2023-06-01 date: 2023-09-05 date: 2024-01-01 date: 2024-02-20 date: 2024-02-20 name: Cairo University class: OTHER briefSummary: To evaluate the effect of core stability exercise on symmetrical weight bearing in chronic stroke patients? conditions: Stroke studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: TREATMENT masking: NONE count: 40 type: ACTUAL name: core stability exercise measure: Each patient was assessed by Balance Berg scales pretreatment. and repeated Measurements were taken after treatment. Each patient was assessed by Digital weight scale and Balance Berg scales measure: Each patient was assessed by Digital weight scale pre treatment and repeated Measurements were taken after treatment. sex: ALL minimumAge: 50 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: faculty of physical therapy Cairo university city: Cairo country: Egypt lat: 30.06263 lon: 31.24967 hasResults: False
nctId: NCT06267066 id: MD-232-2022 briefTitle: Fractional Carbon Dioxide Laser: A Novel Therapeutic Option for Lichen Simplex Chronicus overallStatus: NOT_YET_RECRUITING date: 2024-03-01 date: 2024-08-01 date: 2024-08-30 date: 2024-02-20 date: 2024-02-20 name: Cairo University class: OTHER briefSummary: The goal of this randomized control trial is to compare the use of fractional carbon dioxide (Co2) laser to topical corticosteroids to treat lichen simplex chronicus (LSC) patients presenting to Dermatology outpatient clinic, Faculty of Medicine, Cairo University.
improve more in which group of patients after treatment. conditions: Lichen Simplex Chronicus studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Sixty patients will be divided randomly through closed envelop technique into 2 groups (Group A and B) each of 30 patients. Group A will be subdivided into 2 groups (1 and 2) each of 15 patients. All LSC lesions will be treated in any patient having multiple lesions.
Group B: Patients will be prescribed topical steroids twice daily and topical emollient once daily for 3 months. primaryPurpose: TREATMENT masking: SINGLE maskingDescription: Experienced dermatologist blinded to the interventions done will assess the patients' at the end of the treatment period. whoMasked: OUTCOMES_ASSESSOR count: 60 type: ESTIMATED name: Betamethasone Valerate 0.1% Cream name: SmartXide® fractional carbon dioxide laser name: Vaseline Topical Product measure: Comparison between 2 groups regarding change in Pruritus severity scale measure: Comparison between 2 groups regarding change in Visual analogue scale measure: Comparison between 2 groups regarding change in Investigator's Global Assessment. measure: Comparison between 2 groups regarding change in Scaling score measure: Comparison between 2 groups regarding change in Erythema score measure: Comparison between 2 groups regarding change in Lichenification score measure: Comparison between 2 groups regarding change in Excoriation score measure: change of depression score in both groups. measure: change of itching mediators' levels (IL-31, Nerve Growth Factor and substance) between 2 groups measure: Comparison of itching mediator's levels in lesional, non-lesional skin and healthy controls sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Lobna Alieldin city: Cairo zip: 11562 country: Egypt name: Noha Asem, professor role: CONTACT phone: 01003657120 phoneExt: 20 email: kasralainirec@yahoo.com name: Lobna Alieldin, MSc role: CONTACT phone: 01002279968 phoneExt: 20 email: Lobnaalieldin@gmail.com name: Lobna Alieldin role: PRINCIPAL_INVESTIGATOR lat: 30.06263 lon: 31.24967 facility: Lobna Alieldin city: Cairo zip: 11562 country: Egypt lat: 30.06263 lon: 31.24967 hasResults: False
nctId: NCT06267053 id: 2023/469 briefTitle: Relationship Between Vitamins and Radiologic Stage in Knee Osteoarthritis overallStatus: COMPLETED date: 2023-12-01 date: 2024-01-20 date: 2024-01-20 date: 2024-02-20 date: 2024-02-20 name: Bakirkoy Dr. Sadi Konuk Research and Training Hospital class: OTHER_GOV briefSummary: The aim of this study is to investigate the relationship between folic acid, vitamin B12 and 25-OH vitamin D levels and radiographic staging in patients diagnosed with primary gonarthrosis. conditions: Knee Osteoarthritis studyType: OBSERVATIONAL observationalModel: CASE_ONLY timePerspective: CROSS_SECTIONAL count: 104 type: ACTUAL name: Direct digital radiography name: 25-OH Vitamin D name: Vitamin B12 name: Folic acid measure: 25-OH Vitamin D (25(OH)D) and Kellgren Lawrence Grade measure: Vitamin B12 and Kellgren Lawrence Grade measure: Folic acid and Kellgren Lawrence Grade sex: ALL minimumAge: 50 Years maximumAge: 80 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Bakirkoy Dr. Sadi Konuk Research and Training Hospital city: Istanbul country: Turkey lat: 41.01384 lon: 28.94966 hasResults: False
nctId: NCT06267040 id: 17 Al-KindyCM briefTitle: Linguistic and Clinical Validation of the Arabic Version of Acute Cystitis Symptom Score (ACCS) overallStatus: RECRUITING date: 2023-09-01 date: 2024-04-15 date: 2024-04-30 date: 2024-02-20 date: 2024-04-16 name: Al-Kindy College of Medicine class: OTHER briefSummary: The goal of this prospective observational study is to provide an Arabic translation of the Acute Cystitis Symptom Score (ACSS) and to test the linguistic validity and clinical reliability of the translated Arabic version of ACCS (Arabic-ACCS) in Arabic-speaking women older than 18 years of age diagnosed with uncomplicated cystitis.
Researchers will compare the results from the patients who filled out the first part of the questionnaire with the results of a comparable group of women who were presented with complaints unrelated to the lower urinary tract. conditions: Cystitis Acute studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 200 type: ESTIMATED measure: Linguistic validity measure: Clinical reliability sex: FEMALE minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Al-Elwiya Maternity Teaching Hospital status: RECRUITING city: Baghdad zip: 10064 country: Iraq name: Zahraa Muhmmed Jameel Al-Sattam, FICMS (Gyn.) role: PRINCIPAL_INVESTIGATOR name: Weqar Akram Hussein, FICMS (Gyn.) role: SUB_INVESTIGATOR lat: 33.34058 lon: 44.40088 facility: Alkindy Teaching Hospital status: RECRUITING city: Baghdad zip: 10064 country: Iraq name: Harth Mohamed Kamber, FICMS (Uro.) role: CONTACT phone: +9647706029071 email: harthkamber@kmc.uobaghdad.edu.iq name: Harth Mohamed Kamber, FICMS (Uro.) role: PRINCIPAL_INVESTIGATOR name: Ahmed Abed Marzook, FICMS role: SUB_INVESTIGATOR lat: 33.34058 lon: 44.40088 hasResults: False
nctId: NCT06267027 id: 2022/125 briefTitle: Comparison of Different Physical Therapy Modalities in Lateral Epicondylitis overallStatus: COMPLETED date: 2023-02-07 date: 2023-09-15 date: 2023-12-15 date: 2024-02-20 date: 2024-02-20 name: Bakirkoy Dr. Sadi Konuk Research and Training Hospital class: OTHER_GOV briefSummary: Comparison of the effects of kinesiotaping and high intensity laser therapy in patients with lateral epicondylitis: a randomized controlled study conditions: Lateral Epicondylitis studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: RANDOMIZED CONTROLLED STUDY primaryPurpose: TREATMENT masking: SINGLE whoMasked: INVESTIGATOR count: 55 type: ACTUAL name: Exercise name: Kinesiotaping name: High intensity laser therapy measure: Patient Rated Tennis Elbow Evaluation (PRTEE) measure: Visual Analogue Scale (VAS) measure: Quick Disabilities of the Arm, Shoulder and Hand (qDASH) measure: Jamar's handheld dynamometer sex: ALL minimumAge: 18 Years maximumAge: 75 Years stdAges: ADULT stdAges: OLDER_ADULT facility: BakirkoySadiKonuk city: Bakırköy state: İstanbul zip: 34147 country: Turkey hasResults: False
nctId: NCT06267014 id: 2023-A02163-42 briefTitle: Use of a Virtual Reality Cognitive Stimulation Programme for Breast Cancer Patients Wishing to Restart or Maintain a Professional Activity acronym: Cog-RV overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2025-06 date: 2025-06 date: 2024-02-20 date: 2024-02-20 name: Centre Francois Baclesse class: OTHER briefSummary: The study concerns patients who have been treated for breast cancer, have cognitive problems and are planning to return to work or are currently working and wish to begin cognitive rehabilitation.
Patients will follow the Virtual Reality program developed for the study, during the cognitive rehabilitation usually proposed in the establishment, at the rate of a weekly session of 10-15 minute for 6 weeks. conditions: Breast Cancer conditions: Cancer-related Cognitive Difficulties studyType: INTERVENTIONAL phases: NA allocation: NA interventionModel: SINGLE_GROUP interventionModelDescription: Patients will follow the Virtual Reality program developed for the study, during the cognitive rehabilitation sessions primaryPurpose: SUPPORTIVE_CARE masking: NONE count: 23 type: ESTIMATED name: Virtual Reality sessions measure: Proportion of patients adhering to the Virtual Reality program sex: FEMALE minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Centre François Baclesse city: Caen country: France name: Adeline MOREL, MD role: CONTACT lat: 49.18585 lon: -0.35912 hasResults: False
nctId: NCT06266988 id: SCVL-TFZ-1010 briefTitle: A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions overallStatus: NOT_YET_RECRUITING date: 2024-03 date: 2024-04 date: 2024-08 date: 2024-02-20 date: 2024-02-20 name: Viatris Inc. class: INDUSTRY briefSummary: Primary objective is to is to evaluate the bioequivalence of two formulations conditions: Chronic Heart Failure studyType: INTERVENTIONAL phases: PHASE1 allocation: RANDOMIZED interventionModel: CROSSOVER primaryPurpose: HEALTH_SERVICES_RESEARCH masking: NONE count: 48 type: ESTIMATED name: Sacubitril and Valsartan Tablets 97mg/103mg name: Entresto (Sacubitril and Valsartan Tablets 97mg/103mg) measure: Bioequivalence based on Cmax period (using the validated Phoenix® WinNonlin® software) measure: Bioequivalence based on AUC period (using the validated Phoenix® WinNonlin® software) sex: ALL minimumAge: 18 Years maximumAge: 55 Years stdAges: ADULT hasResults: False
nctId: NCT06266975 id: CKD pts in CML briefTitle: Chronic Kidney Disease Patient in Chronic Myloied Leukemia overallStatus: NOT_YET_RECRUITING date: 2024-02 date: 2026-11 date: 2026-11 date: 2024-02-20 date: 2024-02-20 name: Sahar Mohammed Gad class: OTHER briefSummary: To study the Prevalence ,Characteristics and outcome of CKD in patiants with chronic myeloid leukemia . conditions: Chronic Myeloid Leukemia in Remission studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: CROSS_SECTIONAL count: 40 type: ESTIMATED name: Biobsy from kidney measure: Chronic Kidney Disease Patient in Chronic Myloied Leukemia sex: ALL minimumAge: 18 Years maximumAge: 75 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06266962 id: 3/24 briefTitle: Comparing the Efficiency of Two Approaches in Patients at Risk of Developing Intraoperative Floppy Iris Syndrome overallStatus: COMPLETED date: 2020-07-01 date: 2022-09-30 date: 2022-09-30 date: 2024-02-20 date: 2024-02-20 name: University Hospital Olomouc class: OTHER name: Palacky University briefSummary: Intraoperative Floppy Iris Syndrome (IFIS) is a potentially serious cataract surgery complication. IFIS is most commonly associated with the chronic use of tamsulosin and other alpha1-adrenergic receptor antagonists prescribed in low urinary tract symptoms. There are a number of guidelines for operative technique modifications with the aim to prevent the development of IFIS. The study focuses on two options for prophylactic strategies: the application of atropine drops and the instillation of intracameral epinephrine. conditions: Intraoperative Floppy Iris Syndrome conditions: Cataract conditions: Age-related Cataract conditions: Adrenergic Receptor Antagonist Adverse Reaction studyType: INTERVENTIONAL phases: PHASE4 allocation: NON_RANDOMIZED interventionModel: PARALLEL primaryPurpose: PREVENTION masking: NONE count: 164 type: ACTUAL name: 1% Atropine drops name: Epinephrine measure: Development of IFIS measure: Severity of IFIS measure: Incidence of intraoperative complications sex: MALE minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Department of Ophthalmology, University Hospital Olomouc city: Olomouc country: Czechia lat: 49.59552 lon: 17.25175 hasResults: False
nctId: NCT06266949 id: 11362 briefTitle: Perimetry Based on Eye-movements in Patients With (Supra)Sellar Tumors overallStatus: NOT_YET_RECRUITING date: 2024-04-01 date: 2024-12-01 date: 2025-04-01 date: 2024-02-20 date: 2024-02-20 name: University Medical Center Groningen class: OTHER briefSummary: The purpose of this study is to assess wether the SONDA visual field test is suitable for patients with a supra sellar tumour. conditions: Pituitary Tumor conditions: Visual Fields Hemianopsia studyType: OBSERVATIONAL observationalModel: CASE_CONTROL timePerspective: PROSPECTIVE count: 30 type: ESTIMATED name: SONDA measure: Convert validity measure: Test-retest reliability measure: Experience sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: UMCG city: Groningen zip: 9713 GZ country: Netherlands lat: 53.21917 lon: 6.56667 hasResults: False
nctId: NCT06266936 id: EssaiClinique_SL2i-MSC briefTitle: Smart Life Smart Living Intercontinental - Medical Students' Cohort acronym: SL2i-MSC overallStatus: NOT_YET_RECRUITING date: 2024-09 date: 2044-09 date: 2044-12 date: 2024-02-20 date: 2024-04-17 name: University Hospital, Grenoble class: OTHER name: Université Grenoble-Alpes briefSummary: The question of the well-being, quality of life and mental health of care students is unanimously considered to be a central issue among young adults. According to the French Ministry of Higher Education and Research, there will be 194,752 care students in France in 2021-2022. The quality of life and well-being of health students can be affected at several levels. The first is mental health. In France, the mental health of these students has deteriorated considerably in recent years. According to a 2017 survey of 21,768 French medical students, 66% of them had an anxiety disorder and 27% a depressive syndrome. In addition, a number of risk factors have been identified for the mental health of health students.
The aim of the study is to carry out a longitudinal evaluation of the mental health status of care students during their university studies in France through anxiety, depression and perceived stress. conditions: Mental Health Issue conditions: Student Burnout studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 1564 type: ESTIMATED name: No intervention measure: Synthetic score on standardized assessment scale of anxiety measure: Synthetic score on standardized assessment scale of mental health measure: Synthetic score on standardized assessment scale of stress sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06266923 id: SPH6516-101 briefTitle: A Clinical Study of SPH6516 Tablets in the Treatment of Advanced Solid Tumors. overallStatus: COMPLETED date: 2022-01-20 date: 2023-04-20 date: 2023-11-01 date: 2024-02-20 date: 2024-02-20 name: Shanghai Pharmaceuticals Holding Co., Ltd class: INDUSTRY briefSummary: To evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of SPH6516 tablets in the treatment of advanced solid tumors. conditions: Advanced Solid Tumor studyType: INTERVENTIONAL phases: EARLY_PHASE1 allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 16 type: ACTUAL name: SPH6516 tablets measure: MTD（Maximum tolerated dose） measure: Incidence of Treatment-Emergent Adverse Events measure: Peak Plasma Concentration (Cmax） measure: Peak time（Tmax） measure: Area under the plasma concentration versus time curve (AUC) measure: half-life（T1/2） measure: Objective response rate(ORR) measure: Progression-free survival (PFS) sex: ALL minimumAge: 18 Years maximumAge: 70 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Sun Yat-sen University Cancer Center city: Guangzhou country: China lat: 23.11667 lon: 113.25 facility: Ruijin Hospital, Shanghai Jiaotong University School Of Medicine city: Shanghai country: China lat: 31.22222 lon: 121.45806 hasResults: False